Geode Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.4M | Sell |
7,750,399
-216,986
| -3% | -$2.45M | 0.01% | 1105 |
|
|
2025
Q1 | $80.4M | Buy |
7,967,385
+195,554
| +3% | +$1.97M | 0.01% | 1102 |
|
|
2024
Q4 | $92M | Buy |
7,771,831
+26,727
| +0.3% | +$316K | 0.01% | 1063 |
|
|
2024
Q3 | $89.4M | Buy |
7,745,104
+1,460,205
| +23% | +$16.9M | 0.01% | 1065 |
|
|
2024
Q2 | $66.4M | Buy |
6,284,899
+238,053
| +4% | +$2.52M | 0.01% | 1167 |
|
|
2024
Q1 | $63.7M | Buy |
6,046,846
+522,270
| +9% | +$5.51M | 0.01% | 1186 |
|
|
2023
Q4 | $62.1M | Buy |
5,524,576
+306,396
| +6% | +$3.44M | 0.01% | 1202 |
|
|
2023
Q3 | $61M | Buy |
5,218,180
+2,478,175
| +90% | +$28.9M | 0.01% | 1097 |
|
|
2023
Q2 | $27.6M | Buy |
2,740,005
+1,118,562
| +69% | +$11.3M | ﹤0.01% | 1643 |
|
|
2023
Q1 | $12M | Buy |
1,621,443
+95,750
| +6% | +$707K | ﹤0.01% | 2139 |
|
|
2022
Q4 | $12.2M | Buy |
1,525,693
+81,607
| +6% | +$652K | ﹤0.01% | 2123 |
|
|
2022
Q3 | $4.65M | Buy |
1,444,086
+59,614
| +4% | +$192K | ﹤0.01% | 2720 |
|
|
2022
Q2 | $5.63M | Buy |
1,384,472
+94,293
| +7% | +$384K | ﹤0.01% | 2638 |
|
|
2022
Q1 | $6.37M | Buy |
1,290,179
+130,042
| +11% | +$642K | ﹤0.01% | 2648 |
|
|
2021
Q4 | $11.7M | Buy |
+1,160,137
| New | +$11.7M | ﹤0.01% | 2344 |
|